Publications:70
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Nikhil Waingankar, MD
Urology
About Me
Dr. Nikhil Waingankar joined Mount Sinai as a Urologist in 2016. After earning his medical degree from the University of Oklahoma College of Medicine, Dr. Waingankar completed his internship in General Surgery at Johns Hopkins. He then moved to North Shore Long Island Jewish Health System for his residency in Urology, where he served as Chief Resident during his final year. To complete his training, Dr. Waingankar completed his fellowship In Urologic Oncology at Fox Chase Cancer Center before earning his Masters of Science from UPenn. With his board certification by the American Board of Urology, Dr. Waingankar specializes in urologic oncology with expertise in open, laparoscopic, endoscopic, and robotic surgical techniques.
In addition to his clinical role, Dr. Waingankar serves as Assistant Professor of Vascular Surgery at The Icahn School of Medicine. He is also a member of the American Urological Association and the Society of Urologic Oncology. Throughout his career, Dr. Waingankar has authored several publications and book chapters, as well as given numerous presentations at national meetings.
Dr. Waingankar has conducted extensive research in health services. He is currently involved in research at the Institute for Healthcare Delivery Science with the Mount Sinai Deptartment of Population Health Science and Policy. His research team aims to examine the impacts of care intensity and variations in practice patterns on patient outcomes both at the national level and within The Mount Sinai Health System.
Language
English
Position
ASSOCIATE PROFESSOR | Urology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Adrenalectomy
- Adrenocortical Carcinoma
- Benign Prostatic Hyperplasia
- Bladder Cancer
- Bladder Stone
- Cystoscopy
- Elevated PSA
- Evaluation of Kidney Mass
- Hydronephrosis
- Kidney Cancer
- Kidney Stones
- Nephrectomy
- Penile Cancer
- Prostate Biopsy
- Prostate Cancer
- Prostate Cancer Screening
- Prostate Laser Procedures
- Prostate-Specific Antigen (PSA) Test
- Prostatectomy
- Pyeloplasty
- Radical Cystectomy
- Robotic Kidney Surgery
- Robotic Prostate Surgery
- Testicular Cancer
- Ureteroscopy
- Urology Second Opinion
Education
MD, University of Oklahoma College of Medicine
Internship, Surgery (General Surgery)
Johns Hopkins Hospital
Residency, Urology
North Shore Long Island Jewish Health System
Fellowship, Urologic Oncology
Fox Chase Cancer Center
Certifications
American Board of Urology
Research
Cancer
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VNSNY Select Health Medicaid
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Efficacy of Bacillus Calmette-Guérin compared to sequential gemcitabine and docetaxel in Ta high-grade non-muscle invasive bladder cancer. Ahmed Eraky, Brenda Hug, Reuben Ben-David, Kaushik P. Kolanukuduru, Nikhil Waingankar, Kyrollis Attalla, Peter Wiklund, Reza Mehrazin, John P. Sfakianos. World Journal of Urology
- Differential response of low- and high-grade intermediate-risk non-muscle-invasive bladder cancer to bacillus Calmette-Guérin and gemcitabine-docetaxel therapy. Ahmed Eraky, Kaushik P. Kolanukuduru, Brenda Hug, Reuben Ben-David, Kyrollis Attalla, Nikhil Waingankar, Peter Wiklund, Reza Mehrazin, John P. Sfakianos. Urologic Oncology: Seminars and Original Investigations
- Pheochromocytoma and Paragangliomas: Current Management Strategies. Reuben Ben-David, Ahmed Eraky, Reza Mehrazin, Nikhil Waingankar. Urologic Clinics of North America
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.7 out of 5
Care Provider’s Concern
4.9 out of 5
Likelihood to Recommend Care Provider
4.6 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Waingankar has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.